20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-22-HOMO-21-NORVITAMIN-D3
Compound with spectra: 1 NMR
![20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-22-HOMO-21-NORVITAMIN-D3](/api/compound/DQUvDVxm3i5.png?ph=true&h=300&w=458 "20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-22-HOMO-21-NORVITAMIN-D3")
| SpectraBase Compound ID | DQUvDVxm3i5 |
|---|---|
| InChI | InChI=1S/C39H72O3Si2/c1-30-32(28-33(41-43(10,11)36(2,3)4)29-35(30)42-44(12,13)37(5,6)7)23-22-31-20-18-26-39(27-19-21-34(31)39)25-17-15-14-16-24-38(8,9)40/h22-23,33-35,40H,1,14-21,24-29H2,2-13H3/b31-22+,32-23-/t33-,34+,35+,39-/m1/s1 |
| InChIKey | DFXBADZMLBQYLQ-QHROYQSWSA-N |
| Mol Weight | 645.2 g/mol |
| Molecular Formula | C39H72O3Si2 |
| Exact Mass | 644.501999 g/mol |
| Enantiomer InChIKey | DFXBADZMLBQYLQ-SXOTYAIRSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD2Cl2 |
20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-22,23-DIHOMO-21-NORVITAMIN-D3
20-(17->18)-ABEO-3-(TERT.-BUTYLDIMETHYLSILYL)-1-ALPHA-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-25-HYDROXY-21-NORVITAMIN-D3
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aS)-7a-(4-hydroxy-4-methyl-pentyl)-1-isopropenyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
1-.alpha.-Hydroxy-20-oxo-pregnacalciferol
9,10-Secocholesta-5,7,10(19)-triene-3,21,25-triol, (3.beta.,5Z,7E)-
25S,26-Dihydroxy-cholecalciferol
25-HYDROXY-5,6-TRANS-VITAMIN-D3
9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3.beta.,5Z,7E)-
25-HYDROXYVITAMIN-D3
Ergocalciferol II
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of Novel Analogues of 1α,25-Dihydroxyvitamin D3 with Side Chains at C-18 | The Journal of Organic Chemistry | 2004 |